DocGo Inc reports results for the quarter ended September 30 - Earnings Summary

Reuters11-09
DocGo Inc reports results for the quarter ended September 30 - Earnings Summary
  • DocGo Inc DCGO.OQ reported quarterly adjusted earnings of 5 cents​​ per share for the quarter ended September 30, identical to the same quarter last year. The mean expectation of seven analysts for the quarter was for earnings of 5 cents per share. Wall Street expected results to range from 3 cents to 9 cents per share.

  • Revenue fell 25.7% to $138.68 million from a year ago; analysts expected $137.89 million.

  • DocGo Inc's reported EPS for the quarter was 5 cents​.

  • The company reported quarterly net income of $5.5 million.

  • DocGo Inc shares had risen by 8.7% this quarter and lost 35.4% so far this year.

FORECAST CHANGES

  • The mean earnings estimate of analysts was unchanged in the last three months.​

  • In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 7 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

  • The average consensus recommendation for the healthcare facilities & services peer group is also "buy"

Wall Street's median 12-month price target for DocGo Inc is 6.50

This summary was machine generated from LSEG data November 8 at 04:29 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING

ESTIMATE

ACTUAL

BEAT, MET, MISSED

Sep. 30 2024

0.05

0.05

Met

Jun. 30 2024

0.08

0.07

Missed

Mar. 31 2024

0.08

0.10

Beat

Dec. 31 2023

0.10

0.07

Missed

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment